Faculty News
Steven A. Rosenberg selected as Icon in Surgery by ACS
Steve Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, has been selected as an Icon in Surgery by the American College of Surgeons. He is being highlighted for being a pioneer in the development of oncologic immunotherapy and gene therapy for patients with advanced cancer. Dr. Rosenberg will be giving a video-based presentation at the 2022 ACS Clinical Congress to discuss his work.
Read More
Sung-Yun Pai selected for Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program
Sung-Yun Pai, M.D., Chief of the Immune Deficiency Cellular Therapy Program, was selected for the Hedwig van Ameringen Executive Leadership in Academic Medicine® (ELAM) Program for Women at Drexel University College of Medicine. The ELAM® program is dedicated to developing leadership and management skills in healthcare and is designed for senior-level women leaders interested in advancing hospitals and healthcare systems.
Read More
In Memoriam: Joost J. Oppenheim, M.D. (1934–2022)
The CCR mourns the recent passing of colleague and friend Joost Oppenheim, M.D., Senior Investigator and Head of the Cellular Immunology Section in the Cancer Innovation Laboratory.
Read More
Four CCR researchers receive high honors
CCR Senior Investigators Michael Lichten, Ph.D., Deborah Morrison, Ph.D., Mary Carrington, Ph.D, and Susan Lea, D.Phil., F.Med.Sci., have been elected to notable scientific academies and societies in recognition of their significant and impactful research accomplishments.
Read More
Elaine S. Jaffe receives HHS Career Achievement Award
Elaine S. Jaffe, M.D., NIH Distinguished Investigator in the Laboratory of Pathology, was awarded a 2022 Career Achievement Award by the Department of Health and Human Services in recognition of her groundbreaking advances in the diagnosis and treatment of patients with blood cancers.
Read More
Kandice Tanner receives Arthur S. Flemming Award
Kandice Tanner, Ph.D., a Senior Investigator in the Laboratory of Cell Biology, is a recipient of the 2021 Arthur S. Flemming Awards, which honor the accomplishments of midcareer federal employees. Dr. Tanner received the award for her breakthrough discovery that patterns of cancer spread in humans can be recreated in zebrafish. This novel animal model allows researchers to address organ-specific drug responses and develop effective immunotherapies in a preclinical platform.
Read More
CCR scientists to present at 2022 AACR Annual Meeting in New Orleans
The American Association for Cancer Research (AACR) Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. Several CCR scientists will present their research at the AACR Annual Meeting.
Read More
Steven Pavletic named Top Ten Clinical Research Achievement awardee
Steven Z. Pavletic, M.D., M.S., Senior Clinician in the Immune Deficiency Cellular Therapy Program, has been named a Top Ten Clinical Research Achievement awardee by the Clinical Research Forum for his study “A randomized phase 2 trial of pomalidomide in subjects failing prior therapy for chronic graft-versus-host disease.”
Read More
Anish Thomas explains the challenges and goals of his small cell lung cancer research
Anish Thomas, M.B.B.S., M.D., Lasker Clinical Research Scholar in the Developmental Therapeutics Branch, studies small cell lung cancer (SCLC). For Lung Cancer Awareness Month, Thomas describes his current research interests and his goals to help improve the lives of patients with SCLC – the most lethal type of lung cancer.
Read More
Rosenberg, Waldmann named 2021 Fellows of the Academy of Immuno-Oncology
Steven A. Rosenberg, M.D., Ph.D., Chief of the Surgery Branch, and Thomas A. Waldmann, M.D., Chief Emeritus of the Lymphoid Malignancies Branch (honored posthumously), have been named 2021 Fellows of the Academy of Immuno-Oncology, one of the most prestigious honors from the Society for Immunotherapy of Cancer (SITC). The Academy of Immuno-Oncology was established to honor individuals who have launched the field of cancer immunotherapy into the breakthrough cancer treatment it is today and to bring together the brightest minds in the field to continue to advance SITC, the field and the next generation of immuno-oncologists.
Read More